| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.6B | $5.3B | $5.0B | $4.6B | $4.1B | $0.9B | $1.0B | $0.9B |
| Cost of Revenue | $1.5B | $1.5B | $1.5B | $1.4B | $1.3B | $1.3B | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.8B | $1.6B | $1.5B | $1.4B | $1.3B | $1.3B | $1.2B | $1.1B |
| Operating Income | $2.2B | $2.2B | $2.0B | $1.8B | $1.5B | $0.3B | $0.3B | $0.3B |
| Net Income | $1.7B | $1.7B | — | — | — | — | — | — |
| EPS (Basic) | $4.60 | $4.69 | $4.32 | $3.86 | $3.05 | $0.62 | $0.64 | $0.64 |
| EPS (Diluted) | $4.58 | $4.67 | $4.30 | $3.84 | $3.03 | $0.61 | $0.64 | $0.63 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.6B | $10.4B | $10.5B | $9.6B | $9.2B | $8.6B | $8.7B | $7.5B |
| Current Assets | $8.9B | $7.3B | $7.5B | $6.6B | $6.2B | $5.5B | $5.7B | $5.8B |
| Cash & Equivalents | $1.6B | $1.5B | $1.2B | $0.4B | $1.0B | $0.9B | $0.7B | $0.4B |
| Total Liabilities | $12.4B | $6.6B | $7.1B | $6.5B | $6.3B | $5.8B | $6.1B | $5.4B |
| Current Liabilities | $7.0B | $5.3B | $5.8B | $5.3B | $4.9B | $4.4B | $4.8B | $5.3B |
| Stockholders' Equity | $4.1B | $3.8B | $3.5B | $3.1B | $2.9B | $2.8B | $2.6B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.9B | $1.9B | $1.7B | $1.5B | $1.3B | $1.4B | $1.3B | $1.3B |
| Investing Cash Flow | $-3.4B | $-0.3B | $0.2B | $-1.4B | $-0.5B | $0.8B | $-1.6B | $-0.7B |
| Capital Expenditures | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| Financing Cash Flow | $2.3B | $-1.9B | $-0.7B | $-1.0B | $-0.6B | $-1.5B | $-1.0B | $-0.4B |